(Q53261686)

12 May 2018

title

MicroRNA-101 suppresses SOX9-dependent tumorigenicity and promotes favorable prognosis of human hepatocellular carcinoma. (English)

1 reference

12 May 2018

1 reference

Yanqiong Zhang

1

1 reference

12 May 2018

Xiaodong Guo

2

1 reference

12 May 2018

Lu Xiong

3

1 reference

12 May 2018

Xiangying Kong

4

1 reference

12 May 2018

Ying Xu

5

1 reference

12 May 2018

Chunfang Liu

6

1 reference

12 May 2018

Lin Zou

7

1 reference

12 May 2018

Zhiwei Li

8

1 reference

12 May 2018

Jingmin Zhao

9

1 reference

12 May 2018

Na Lin

10

1 reference

12 May 2018

language of work or name

English

0 references

publication date

21 November 2012

1 reference

12 May 2018

published in

FEBS Letters

1 reference

12 May 2018

volume

586

1 reference

12 May 2018

issue

24

1 reference

12 May 2018

page(s)

4362-4370

1 reference

12 May 2018

Global cancer statistics, 2002

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.053

Primary liver cancer: worldwide incidence and trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.053

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.053

Oncomirs - microRNAs with a role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.053

MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.053

Identification of postoperative prognostic microRNA predictors in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.053

Campomelic dysplasia and autosomal sex reversal caused by mutations in an SRY-related gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.053

Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.053

Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.053

SOX9 is expressed in human fetal prostate epithelium and enhances prostate cancer invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.053

Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.053

Expression and biological role of the prostaglandin D synthase/SOX9 pathway in human ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.053

Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.053

Regulation of human chondrocyte function through direct inhibition of cartilage master regulator SOX9 by microRNA-145 (miRNA-145)

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.053

Prediction of mammalian microRNA targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.053

Prediction of microRNA targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.053

MicroRNAs: control and loss of control in human physiology and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.053

MicroRNA-101 negatively regulates Ezh2 and its expression is modulated by androgen receptor and HIF-1alpha/HIF-1beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.053

Genomic loss of microRNA-101 leads to overexpression of histone methyltransferase EZH2 in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.053

MicroRNA-101 (miR-101) post-transcriptionally regulates the expression of EP4 receptor in colon cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.053

MicroRNA-101 inhibits growth of epithelial ovarian cancer by relieving chromatin-mediated transcriptional repression of p21(waf¹/cip¹).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.053

MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.053

MicroRNA-101 regulates expression of the v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS) oncogene in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2012.10.053

10.1016/J.FEBSLET.2012.10.053

21 January 2018

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018